New strategies are needed in diffuse malignant mesothelioma

Background. Medical records of 50 patients with malignant mesothelioma were reviewed to determine the clinical features and factors influencing survival.

[1]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[2]  E. Gehan,et al.  A generalized two-sample Wilcoxon test for doubly censored data. , 1965, Biometrika.

[3]  R. Shemin,et al.  Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  E. Salewski,et al.  A phase II study of pirarubicin in malignant pleural mesothelioma , 1990, Cancer.

[5]  C. A. van der Merwe,et al.  Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  N. Martini,et al.  Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma. , 1984, International journal of radiation oncology, biology, physics.

[7]  G. Scagliotti,et al.  Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II study , 1991, Cancer.

[8]  David A. Amato,et al.  EARLY PERITONEAL MESOTHELIOMA: A TREATABLE MALIGNANCY , 1985, The Lancet.

[9]  P. Bye,et al.  Phase II trial of carboplatin in the management of malignant mesothelioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  H. Bloom,et al.  Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. , 1984, Thorax.

[11]  F M Muggia,et al.  Pleural mesothelioma: clinical features and therapeutic implications. , 1977, Annals of internal medicine.

[12]  E. Butchart,et al.  Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. , 1976, Thorax.

[13]  N. Dreyer,et al.  Projections of asbestos-related disease 1980-2009. , 1983, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[14]  K. Antman,et al.  Incidence, presentation and promising new treatments for malignant mesothelioma. , 1989, Oncology.

[15]  J. Jett,et al.  Diffuse malignant mesothelioma of pleura: Diagnosis and survival in 92 cases , 1986, Cancer.

[16]  L. Feun,et al.  Activity of pirarubicin (4′‐o‐tetrahydropyranyladriamycin) in malignant mesothelioma , 1989, Cancer.

[17]  R. Thurer,et al.  Brain Metastases in Malignant Pleural Mesothelioma: Case Report and Review of the Literature , 1989, American journal of clinical oncology.

[18]  L. Norton,et al.  Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. , 1982, Annals of internal medicine.

[19]  L. Baker,et al.  Treatment of six cases of mesothelioma with doxorubicin and cisplatin , 1983 .

[20]  L. Norton,et al.  Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma. , 1984, Cancer research.

[21]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[22]  P. Betta,et al.  New marker for mesothelioma: an immunoperoxidase study. , 1986, Journal of clinical pathology.

[23]  C. Kittle.  Mesothelioma: Diagnosis and management , 1987 .

[24]  K. Sridhar,et al.  Clinical features of adenosquamous lung carcinoma in 127 patients. , 1990, The American review of respiratory disease.

[25]  Emil Frei,et al.  Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide , 1960 .

[26]  E. Borden,et al.  Malignant mesothelioma. The eastern cooperative oncology group (ECOG) experience , 1983, Cancer.

[27]  H. Harter.  ‘A new table of percentage points of the chi-square distribution’ , 1964 .

[28]  G. Dabouis,et al.  Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients. , 1988, Chest.

[29]  E. Gehan.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.